Search

Your search keyword '"Multiple myeloma -- Reports"' showing total 1,365 results

Search Constraints

Start Over You searched for: Descriptor "Multiple myeloma -- Reports" Remove constraint Descriptor: "Multiple myeloma -- Reports"
1,365 results on '"Multiple myeloma -- Reports"'

Search Results

2. New Multiple Myeloma Study Findings Have Been Reported by Researchers at National Cancer Institute (NCI) (Irf4 Requires Arid1a To Establish Plasma Cell Identity In Multiple Myeloma)

3. Data on Multiple Myeloma Reported by Researchers at University of Miami (The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans)

4. 2seventy Bio shares will remain range-bound, says Guggenheim

5. 2seventy Bio hares will remain range-bound, says Guggenheim

6. Harvard Medical School Researchers Have Provided New Study Findings on Multiple Myeloma (Mezigdomide-A Novel Cereblon E3 Ligase Modulator under Investigation in Relapsed/Refractory Multiple Myeloma)

7. Researchers from Medical College of Wisconsin Discuss Findings in Multiple Myeloma (Novel Approaches of Cellular Therapy In Multiple Myeloma: Focus On Chimeric Antigen Receptor T-cells)

9. Radboud University Medical Center Researchers Have Published New Study Findings on Multiple Myeloma (Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into ...)

11. Data on Multiple Myeloma Reported by Carlo Augusto Mallio and Colleagues [The Whole-Body MRI Reporting and Data System Guidelines for Prostate Cancer (MET-RADS-P), Multiple Myeloma (MY-RADS), and Cancer Screening (ONCO-RADS)]

13. Reports from Beckman Research Institute Add New Data to Research in Multiple Myeloma (Prospective pooled analyses of ambient ultraviolet radiation levels and risk of non-Hodgkin lymphoma and multiple myeloma)

15. 'The Golden Bachelor' star Gerry Turner says he has bone marrow cancer

16. Refractory Multiple Myeloma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

17. Active Biotech Interim Report Q3 2024

18. Researcher from University of Saskatchewan Reports Recent Findings in Multiple Myeloma (A Novel Single-Tube Next Generation Sequencing Assay for B-Cell Receptor Clonality Testing)

20. Zhejiang University School of Medicine Researcher Describes Recent Advances in Multiple Myeloma (Real-World Data of Maintenance Therapy for Newly Diagnosed Multiple Myeloma: Ixazomib Versus Lenalidomide)

21. Studies in the Area of Multiple Myeloma Reported from H. Lee Moffitt Cancer Center and Research Institute (Acid ceramidase controls proteasome inhibitor resistance and is a novel therapeutic target for the treatment of relapsed / refractory ...)

22. Studies from Dana-Farber Cancer Institute and Harvard Medical School Add New Findings in the Area of Veterans (Development of Novel Peripheral Blood Count-Based Prognostic Index for Multiple Myeloma)

23. Northwell Health Cancer Institute Researcher Has Published New Study Findings on Multiple Myeloma (Predictors of Radiotherapy Utilization and Outcome in Multiple Myeloma: A Single-Center Retrospective Study)

24. Institute of Hematology Researcher Details Findings in Multiple Myeloma (Clinical Implications of Residual Immunophenotypically Normal Plasma Cells within Bone Marrow at Various Disease Stages in Multiple Myeloma)

26. New Multiple Myeloma Study Findings Have Been Published by a Researcher at Institute of Hematology and Blood Diseases Hospital (TRIM28 Serves As a Key Regulator of Protein Homeostasis and Mediates Proteasome Inhibitor Resistance in Multiple ...)

27. New Bone Diseases and Conditions Study Findings Recently Were Published by Researchers at University of Arkansas for Medical Sciences (Novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma)

28. New Study Findings from Institute of Hematology and Blood Diseases Hospital Illuminate Research in Multiple Myeloma (Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma)

29. Reports Outline Solid Cancer Study Findings from National Cancer Institute (NCI) (Car T-cells for Pediatric Solid Tumors: Where To Go From Here?)

30. New Multiple Myeloma Research from Cleveland Clinic Akron General Discussed (Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma)

32. University Health Network Researcher Discusses Findings in Multiple Myeloma (CXCR4-Targeted PET Imaging in Hematologic Malignancies)

33. Netherlands Comprehensive Cancer Organisation Reports Findings in Multiple Myeloma (Health care utilization up to 11 years after diagnosis among patients with a hematologic malignancy and its association with socioeconomic position)

34. Active Biotech Interim Report Q2 2024

35. Active Biotech Interim Report Q1 2024

36. Data on Multiple Myeloma Published by Researchers at Fred Hutchinson Cancer Research Center (Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel)

37. Reports on Multiple Myeloma Findings from National University of Singapore Provide New Insights (Super enhancer acquisition drives expression of oncogenic PPP1R15B that regulates protein homeostasis in multiple myeloma)

38. Data on Multiple Myeloma Discussed by a Researcher at Lung and Blood Institute (Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With ...)

39. Research on Multiple Myeloma Detailed by a Researcher at Clinical Chemistry Laboratory (Characteristics of 15 Subjects Affected by IgD Multiple Myeloma and the Key Role of the Laboratory in Diagnosis: A Retrospective Study Report and Literature ...)

40. Studies from Research Institute of Fundamental and Clinical Immunology Add New Findings in the Area of Multiple Myeloma (Evaluation of granulocyte colony-stimulating factor effect on the expression of inhibitory receptors by T cells in multiple ...)

43. New Findings from Bristol-Myers Squibb Company Describe Advances in Clinical Trial Research (Informing the Recommended Phase Iii Dose of Alnuctamab, a Cd3 X Bcma T-cell Engager, Using Population Pharmacokinetics and Exposure-response Analysis)

44. Findings on Multiple Myeloma Detailed by Investigators at Bristol-Myers Squibb Company (Pharmacodynamic Changes In Tumor and Immune Cells Drive Iberdomide's Clinical Mechanisms of Activity In Relapsed and Refractory Multiple Myeloma)

45. BC Cancer Agency Reports Findings in Myeloma (Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients In The Maintenance Era: Real-world Results From The Canadian Myeloma Research Group Database)

46. Reports Outline Extramedullary Disease Findings from Department of Oncohematology (Extramedullary Disease In Multiple Myeloma: What You Might Not Expect On [18f]Fdg Pet/ct - a Pictorial Essay)

48. Patent Issued for Bortezomib compositions (USPTO 12005069)

50. Arcellx price target raised to $50 from $39 at BofA

Catalog

Books, media, physical & digital resources